Literature DB >> 9895283

A sensitive immunoassay for rat fatty acid translocase (CD36) using phage antibodies selected on cell transfectants: abundant presence of fatty acid translocase/CD36 in cardiac and red skeletal muscle and up-regulation in diabetes.

M M Pelsers1, J T Lutgerink, F A Nieuwenhoven, N N Tandon, G J van der Vusse, J W Arends, H R Hoogenboom, J F Glatz.   

Abstract

The rat membrane protein fatty acid translocase (FAT), which shows sequence similarity to human CD36 (a membrane protein supposedly involved in a variety of membrane processes), is implicated in the transport of long-chain fatty acids across cellular membranes. To set up an immunoassay for quantification of FAT in different tissues, we isolated a series of anti-FAT antibodies by panning a large naive phage antibody library on FAT-transfected H9c2 cells. All seven different phage antibody fragments isolated reacted specifically with FAT, and most likely recognize the same or closely located immunodominant sites on FAT, as a competitive monoclonal antibody (mAb) (CLB-IV7) completely blocked the binding of all these phage antibodies to cells. A sandwich ELISA was set up using mAb 131. 4 (directed against purified CD36 from human platelets) as capture antibody and phage antibodies and anti-phage sera as detector. With this ELISA (sensitivity 0.05 microgram/ml), the FAT content in isolated cardiomyocytes was found to be comparable with that of total heart ( approximately 3 mg/g of protein), while liver tissue and endothelial cells were below the detection limit (<0.1 mg of FAT/g of protein). During rat heart development, protein levels of FAT rose from 1.7+/-0.7 mg/g of protein on the day before birth to 3.6+/-0.4 mg/g of protein on day 70. Comparing control with streptozotocin-induced diabetic rats, a statistically significant (P<0.05) 2-4-fold increase of FAT was seen in heart (from 4.2+/-2.3 to 11.0+/-5.7 mg/g of protein), soleus (from 0.6+/-0.1 to 1.4+/-0.5 mg/g of protein) and extensor digitorum longus (EDL) muscle (from 0.3+/-0.1 to 1. 2+/-0.8 mg/g of protein). In addition, the FAT contents of each of these muscles were found to be of similar magnitude to the contents of cytoplasmic heart-type fatty-acid-binding protein in both diabetic rats and controls, supporting the suggested roles of these two proteins in cellular fatty acid metabolism. This is the first time phage display technology has been succesfully applied for direct selection, from a large naive antibody library, of antibodies that recognize selected membrane proteins in their natural context.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9895283      PMCID: PMC1219991     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  38 in total

Review 1.  Membrane glycoprotein CD36: a review of its roles in adherence, signal transduction, and transfusion medicine.

Authors:  D E Greenwalt; R H Lipsky; C F Ockenhouse; H Ikeda; N N Tandon; G A Jamieson
Journal:  Blood       Date:  1992-09-01       Impact factor: 22.113

Review 2.  Fatty acid homeostasis in the normoxic and ischemic heart.

Authors:  G J van der Vusse; J F Glatz; H C Stam; R S Reneman
Journal:  Physiol Rev       Date:  1992-10       Impact factor: 37.312

3.  Multi-subunit proteins on the surface of filamentous phage: methodologies for displaying antibody (Fab) heavy and light chains.

Authors:  H R Hoogenboom; A D Griffiths; K S Johnson; D J Chiswell; P Hudson; G Winter
Journal:  Nucleic Acids Res       Date:  1991-08-11       Impact factor: 16.971

4.  A sandwich enzyme linked immuno-sorbent assay for the determination of rat heart fatty acid-binding protein using the streptavidin-biotin system. Application to tissue and effluent samples from normoxic rat heart perfusion.

Authors:  M M Vork; J F Glatz; D A Surtel; H J Knubben; G J Van der Vusse
Journal:  Biochim Biophys Acta       Date:  1991-10-31

5.  Fatty acid uptake by isolated rat heart myocytes represents a carrier-mediated transport process.

Authors:  W Stremmel
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Sarcolemmal fatty acid transfer in isolated cardiomyocytes governed by albumin/membrane-lipid partition.

Authors:  H Rose; T Hennecke; H Kammermeier
Journal:  J Mol Cell Cardiol       Date:  1990-08       Impact factor: 5.000

7.  Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats.

Authors:  S R Wall; G D Lopaschuk
Journal:  Biochim Biophys Acta       Date:  1989-11-06

8.  Quantitation of platelet glycoprotein IV (CD36) in healthy subjects and in patients with essential thrombocythemia using an immunocapture assay.

Authors:  V Thibert; S Bellucci; L Edelman; N N Tandon; C Legrand
Journal:  Thromb Haemost       Date:  1992-11-10       Impact factor: 5.249

9.  Labeling of adipocyte membranes by sulfo-N-succinimidyl derivatives of long-chain fatty acids: inhibition of fatty acid transport.

Authors:  C M Harmon; P Luce; A H Beth; N A Abumrad
Journal:  J Membr Biol       Date:  1991-05       Impact factor: 1.843

10.  By-passing immunization. Human antibodies from V-gene libraries displayed on phage.

Authors:  J D Marks; H R Hoogenboom; T P Bonnert; J McCafferty; A D Griffiths; G Winter
Journal:  J Mol Biol       Date:  1991-12-05       Impact factor: 5.469

View more
  20 in total

Review 1.  Role of plasma membrane transporters in muscle metabolism.

Authors:  A Zorzano; C Fandos; M Palacín
Journal:  Biochem J       Date:  2000-08-01       Impact factor: 3.857

Review 2.  Involvement of membrane-associated proteins in the acute regulation of cellular fatty acid uptake.

Authors:  J F Glatz; J J Luiken; A Bonen
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

3.  Microarray analysis reveals novel gene expression changes associated with erectile dysfunction in diabetic rats.

Authors:  Chris J Sullivan; Thomas H Teal; Ian P Luttrell; Khoa B Tran; Mette A Peters; Hunter Wessells
Journal:  Physiol Genomics       Date:  2005-08-23       Impact factor: 3.107

4.  Computational evidence for protein-mediated fatty acid transport across the sarcolemma.

Authors:  Mark W J M Musters; James B Bassingthwaighte; Natal A W van Riel; Ger J van der Vusse
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

5.  Ketone bodies disturb fatty acid handling in isolated cardiomyocytes derived from control and diabetic rats.

Authors:  Danny M Hasselbaink; Jan F C Glatz; Joost J F P Luiken; Theo H M Roemen; Ger J Van der Vusse
Journal:  Biochem J       Date:  2003-05-01       Impact factor: 3.857

6.  Structural and functional characterization of the mouse fatty acid translocase promoter: activation during adipose differentiation.

Authors:  L Teboul; M Febbraio; D Gaillard; E Z Amri; R Silverstein; P A Grimaldi
Journal:  Biochem J       Date:  2001-12-01       Impact factor: 3.857

Review 7.  Regulation of fatty acid transport and membrane transporters in health and disease.

Authors:  Arend Bonen; Joost J F P Luiken; Jan F C Glatz
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

8.  Luminal lipid regulates CD36 levels and downstream signaling to stimulate chylomicron synthesis.

Authors:  Thi Thu Trang Tran; Hélène Poirier; Lionel Clément; Fatiha Nassir; Maurice M A L Pelsers; Valérie Petit; Pascal Degrace; Marie-Claude Monnot; Jan F C Glatz; Nada A Abumrad; Philippe Besnard; Isabelle Niot
Journal:  J Biol Chem       Date:  2011-05-24       Impact factor: 5.157

9.  Fatty acid- and cholesterol transporter protein expression along the human intestinal tract.

Authors:  Christiaan J Masson; Jogchum Plat; Ronald P Mensink; Andrzej Namiot; Wojciech Kisielewski; Zbigniew Namiot; Joachim Füllekrug; Robert Ehehalt; Jan F C Glatz; Maurice M A L Pelsers
Journal:  PLoS One       Date:  2010-04-29       Impact factor: 3.240

10.  Lifestyle changes and lipid metabolism gene expression and protein content in skeletal muscle of subjects with impaired glucose tolerance.

Authors:  M Mensink; E E Blaak; H Vidal; T W A De Bruin; J F C Glatz; W H M Saris
Journal:  Diabetologia       Date:  2003-07-11       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.